Cited by 18Obesity and Health PracticesPharmacology and Obesity TreatmentObesity, Physical Activity, Diet

Effects of Education and Experience on Primary Care Providers' Perspectives of Obesity Treatments during a Pragmatic Trial

Open access
Iwamoto, Sean, Saxon, David, Tsai, Adam, Leister, Erin, Speer, Rebecca, Heyn, Hilde, Kealey, Elizabeth, Juarez‐Colunga, Elizabeth +4 more·2018·Obesity

Abstract

Objective: To examine the impact of a 1‐year pragmatic obesity trial on primary care providers' (PCPs) perspectives of treatment. Methods: PCPs from four intervention clinics (PCP‐I) and five control clinics (PCP‐C) completed pre‐ and postintervention surveys on weight‐loss counseling, comfort discussing obesity treatments, and perceived effectiveness of interventions; questions were rated on 0 to 10 Likert scales. Only PCP‐I received patient updates and education about obesity management. Results: Eighty PCPs completed preintervention surveys (pre: 71% female, 71% physicians); 82 PCPs completed postintervention surveys (post: 66% female, 70% physicians). PCPs were most comfortable discussing exercise before and after the trial (pre PCP‐C: 8.22 [1.44], mean [standard deviation (SD)]; post PCP‐C: 8.37 [1.24]; P = 0.8; pre/post PCP‐I: 7.88 [1.51] vs. 7.80 [1.71]; P = 0.3). PCPs were initially least comfortable discussing phentermine/topiramate extended release (ER) but developed significantly more comfort after the trial, to a greater degree among PCP‐I (pre/post PCP‐C: 2.86 [2.66] vs. 3.73 [2.72], P < 0.001; pre/post PCP‐I: 4.00 [2.57] vs. 6.17 [2.27], P < 0.001). After the trial, both PCPs rated exercise significantly less effective for weight loss, with a greater decrease in effectiveness rations among PCP‐I (pre/post PCP‐C: 7.73 [1.94] vs. 6.93 [2.35], P = 0.017; pre/post PCP‐I: 6.27 [2.69] vs. 5.15 [2.31], P = 0.001). Both PCPs rated phentermine (pre/post PCP‐C: 5.03 [2.05] vs. 5.50 [2.12], P = 0.002; pre/post PCP‐I: 5.70 [1.64] vs. 6.83 [1.18], P = 0.001) and phentermine/topiramate ER (pre/post PCP‐C: 3.91 [2.33] vs. 5.47 [2.54], P < 0.001; pre/post PCP‐I: 5.58 [2.21] vs. 7.02 [1.47], P < 0.001) significantly more effective after the trial, though ratings were higher among PCP‐I. Conclusions: PCPs initially overvalued exercise and undervalued weight‐loss medications. PCPs exposed to education and experience gave higher comfort and effectiveness ratings to weight‐loss medications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/oby.22223

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Individuals with obesity but without diabetes are at elevated risk of developing diabetes and other cardiometabolic conditions compared with individuals without obesity.

    “This subgroup, while sometimes characterized as metabolically healthy due to the lack of prevalent disease, is at elevated risk of developing diabetes and other cardiometabolic conditions compared with individuals without obesity.4,5,6,7”

    From Factors Associated With Semaglutide Initiation Among Adults With Obesity (2025) · cites this paper as [7]

    The Introduction states that obesity increases the risk of common chronic medical conditions, and its references include studies of diabetes incidence and incident hypertension (References; page not provided). The paper does not specifically assess people with obesity but without diabetes against people without obesity, so the claim’s subgroup comparison is not established by this source. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [25]Bessesen DH Van Gaal LF Progress and challenges in anti-obesity pharmacotherapy Lancet Diabetes Endocrinol 2017 28919062

Cited by

Sorted by citations

Authors
Iwamoto, S., Saxon, D., Tsai, A., Leister, E., Speer, R., Heyn, H., Kealey, E., Juarez‐Colunga, E., Gudzune, K., Bleich, S., Clark, J., & Bessesen, D.
Affiliations
  • Denver VA Medical Center (US)
  • VA Eastern Colorado Health Care System (US)
  • Kaiser Permanente (US)
  • Colorado School of Public Health (US)
  • Denver Health Medical Center (US)
  • University of Colorado Anschutz (US)
  • Johns Hopkins University (US)
  • Harvard University (US)
Corresponding author
Iwamoto, Sean
Venue
Obesity
Publisher
Wiley
Published
2018-09-26
Volume
26
Issue
10
Pages
1532-1538
ISSN
  • 1930-7381 (ISSN-L)
  • 1930-739X
OpenAlex
W2894215818
Cited by
18
References
47
Citations by year
2026: 2 · 2025: 4 · 2024: 1 · 2022: 2 · 2021: 4 · 2020: 2 · 2019: 3
FWCI
4.43
Type
journal article
Language
en
Open access
Locations
  • Obesity (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Patient-Centered Outcomes Research Institute (IH‐12‐11‐4571, P30 DK048520, T32 DK007446)
  • National Institutes of Health (UL1 TR001082)
  • Health Services Research and Development
Topics
  • Health Sciences › Health Professions › Pharmacy › Obesity and Health Practices
  • Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Keywords
obesity treatment, primary care providers, weight loss counseling, exercise for weight loss, physician training, pragmatic trials, patient-provider communication
MeSH terms
Adult, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Obesity, Primary Health Care, Surveys and Questionnaires, Physicians, Primary Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review